[1] LIESCHKE G J, BURGESS A W. Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor (2)[J]. N Engl J Med,1992,327(2):99-106. doi:  10.1056/NEJM199207093270207
[2] AZOULAY E, ATTALAH H, HARF A, et al. Granulocyte colony-stimulating factor or neutrophil-induced pulmonary toxicity: myth or reality?: systematic review of clinical case reports and experimental data[J]. Chest,2001,120(5):1695-1701. doi:  10.1378/chest.120.5.1695
[3] AZOULAY E, DARMON M, DELCLAUX C, et al. Deterioration of previous acute lung injury during neutropenia recovery[J]. Crit Care Med,2002,30(4):781-786. doi:  10.1097/00003246-200204000-00010
[4] 邓小军, 徐蜀远, 杨丽萍. 重组人粒细胞刺激因子临床应用安全性评价与合理用药[J]. 中国药业, 2016, 25(19):9-12.
[5] KUBO K, AZUMA A, KANAZAWA M, et al. Consensus statement for the diagnosis and treatment of drug-induced lung injuries[J]. Respir Investig,2013,51(4):260-277. doi:  10.1016/j.resinv.2013.09.001
[6] ALLEN J N, PACHT E R, GADEK J E, et al. Acute eosinophilic pneumonia as a reversible cause of noninfectious respiratory failure[J]. N Engl J Med,1989,321(9):569-574. doi:  10.1056/NEJM198908313210903
[7] ALI M S, GHORI U K, MUSANI A I. Orphan lung diseases[J]. Med Clin N Am,2019,103(3):503-515. doi:  10.1016/j.mcna.2018.12.009
[8] ALLEN J, WERT M. Eosinophilic pneumonias[J]. J Allergy Clin Immunol Pract,2018,6(5):1455-1461. doi:  10.1016/j.jaip.2018.03.011
[9] COTTIN V. Eosinophilic lung diseases[J]. Clin Chest Med,2016,37(3):535-556. doi:  10.1016/j.ccm.2016.04.015
[10] FRANZKE A, PIAO W J, LAUBER J, et al. G-CSF as immune regulator in T cells expressing the G-CSF receptor: implications for transplantation and autoimmune diseases[J]. Blood,2003,102(2):734-739. doi:  10.1182/blood-2002-04-1200
[11] PAN L, DELMONTE J Jr, JALONEN C K, et al. Pretreatment of donor mice with granulocyte colony-stimulating factor polarizes donor T lymphocytes toward type-2 cytokine production and reduces severity of experimental graft-versus-host disease[J]. Blood,1995,86(12):4422-4429. doi:  10.1182/blood.V86.12.4422.bloodjournal86124422
[12] DE GIACOMI F, VASSALLO R, YI E S, et al. Acute eosinophilic pneumonia. causes, diagnosis, and management[J]. Am J Respir Crit Care Med,2018,197(6):728-736. doi:  10.1164/rccm.201710-1967CI
[13] NAKAGOME K, NAGATA M. Possible mechanisms of eosinophil accumulation in eosinophilic pneumonia[J]. Biomolecules,2020,10(4):E638. doi:  10.3390/biom10040638
[14] ROTHENBERG M E, HOGAN S P. The eosinophil[J]. Annu Rev Immunol,2006,24:147-174. doi:  10.1146/annurev.immunol.24.021605.090720
[15] KARLIN L, DARMON M, THIÉRY G, et al. Respiratory status deterioration during G-CSF-induced neutropenia recovery[J]. Bone Marrow Transplant,2005,36(3):245-250. doi:  10.1038/sj.bmt.1705037
[16] TODESCHINI G, MURARI C, BONESI R, et al. Invasive aspergillosis in neutropenic patients: rapid neutrophil recovery is a risk factor for severe pulmonary complications[J]. Eur J Clin Invest,1999,29(5):453-457. doi:  10.1046/j.1365-2362.1999.00474.x
[17] AZOULAY E, ATTALAH H, YANG K, et al. Exacerbation with granulocyte colony-stimulating factor of prior acute lung injury during neutropenia recovery in rats[J]. Crit Care Med,2003,31(1):157-165. doi:  10.1097/00003246-200301000-00025
[18] JHUN B W, KIM S J, KIM K, et al. Outcomes of rapid corticosteroid tapering in acute eosinophilic pneumonia patients with initial eosinophilia[J]. Respirology,2015,20(8):1241-1247. doi:  10.1111/resp.12639
[19] JHUN B W, KIM S J, KIM K, et al. Clinical implications of initial peripheral eosinophilia in acute eosinophilic pneumonia[J]. Respirology,2014,19(7):1059-1065. doi:  10.1111/resp.12342